FMP
Oncopeptides AB (publ)
ONCO.ST
STO
Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.
1.53 SEK
-0.014 (-0.917%)
Valuation Date:
Mar 18, 2025 12:29 PM
Share Price on Valuation Date
$1.53
Stock Beta
-0.448
Shares Outstanding
211263657